Oral anticoagulation and preventing stent thrombosis
This presentation is the property of its rightful owner.
Sponsored Links
1 / 14

Oral Anticoagulation and Preventing Stent Thrombosis PowerPoint PPT Presentation


  • 67 Views
  • Uploaded on
  • Presentation posted in: General

Oral Anticoagulation and Preventing Stent Thrombosis. Unadjusted Kaplan-Meier Survival Curves for STEMI vs NSTEMI. ATLAS ACS 2—TIMI 51: Rivaroxaban. All-cause mortality, non-fatal MI, non-fatal stroke, and severe recurrent ischemia (%); a ll patients received ASA +/- clopidogrel.

Download Presentation

Oral Anticoagulation and Preventing Stent Thrombosis

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Oral anticoagulation and preventing stent thrombosis

Oral Anticoagulation and Preventing Stent Thrombosis


Unadjusted kaplan meier survival curves for stemi vs nstemi

Unadjusted Kaplan-Meier Survival Curves for STEMI vs NSTEMI


Atlas acs 2 timi 51 rivaroxaban

ATLAS ACS 2—TIMI 51: Rivaroxaban


Oral anticoagulation and preventing stent thrombosis

All-cause mortality, non-fatal MI, non-fatal stroke, and severe recurrent ischemia (%); all patients received ASA +/- clopidogrel


Primary safety endpoint major and crnm bleeding at 6 months

Primary Safety Endpoint: Major and CRNM bleeding at 6 months


Stent thrombosis atlas acs 2 timi 51 and appraise 2

Stent Thrombosis: ATLAS ACS 2—TIMI 51 and APPRAISE-2


The thrombin paradox

The Thrombin Paradox


Atlas acs 2 timi 51 mortality

ATLAS ACS 2—TIMI 51: Mortality


Oral anticoagulation and preventing stent thrombosis

Abbreviations ACE = angiotensin-converting enzymeACS = acute coronary syndromeADP = adenosine diphosphateAF = atrial fibrillationAPPRAISE-2 = Apixaban for Prevention of Acute Ischemic Events 2aPC = activated protein CASA = aspirinATLAS ACS 2—TIMI 51 = Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51BID = twice dailyCI = confidence intervalCRNM = clinically relevant, non-majorCURE = Clopidogrel in Unstable Angina to Prevent Recurrent EventsDAPT = dual antiplatelet therapyESTEEM = Efficacy and Safety of the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Recent Myocardial DamageHR = hazard ratioi = inactiveISTH = International Society of Thrombosis and Haemostasis


Oral anticoagulation and preventing stent thrombosis

Abbreviations (cont)MI = myocardial infarctionNSTE-ACS = non-ST segment elevation acute coronary syndromeNSTEMI = non ST-segment elevation myocardial infarctionPAR-1 = protease-activated receptorQD = once dailyRE-DEEM = Randomized Dabigatran Etexilate Dose Finding Study in Patients With Acute Coronary Syndromes Post Index Event With Additional Risk Factors for Cardiovascular Complications Also Receiving Aspirin and Clopidogrel: Multi-centre, Prospective, Placebo Controlled, Cohort Dose Escalation StudyROCKET-AF = Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationRUBY-1 = Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary SyndromesSTEMI = ST-segment elevation myocardial infarctionTF = tissue factor


  • Login